Jubilant Life Sciences Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jubilant Life Sciences Limited with three other
companies in this sector in India:
Piramal Enterprises Limited
sales of 66.10 billion Indian Rupees [US$969.01 million]
of which 54%
Alkem Laboratories Ltd
(49.76 billion Indian Rupees [US$729.47 million]
of which 101%
was Pharma Business), and
Torrent Pharmaceuticals Limited
(66.76 billion Indian Rupees [US$978.76 million]
of which 100%
Jubilant Life Sciences Limited reported sales of 58.02 billion Indian Rupees (US$850.62 million)
March of 2016.
decrease of 0.4%
versus 2015, when the company's sales were 58.26 billion Indian Rupees.
Contributing to the drop in overall sales was the 12.6% decline
in Life Science Ingredients, from 31.50 billion Indian Rupees to 27.53 billion Indian Rupees.
However, these declines were partially offset by the increase in sales of
Pharmaceuticals (up 13.9% to 30.55 billion Indian Rupees)